$Recursion Pharmaceuticals, In

Faro Health and Recursion Partner To Advance AI-powered Clinical Trial Design

PRESS RELEASE FROM FARO HEALTH

SAN DIEGO — Faro Health Inc., the leading AI-powered platform for data-driven clinical protocol design, today announced it has partnered with Recursion (NASDAQ: RXRX) to accelerate and optimize clinical protocol design for Recursion’s portfolio of clinical-stage drug candidates.

Read More At: https://www.biopharmadive.com/press-release/20250114-faro-health-and-recursion-partner-to-advance-ai-powered-clinical-trial-desi-1/

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":393611147780552,"tweetId":"393611147780552","gmtCreate":1737133723605,"gmtModify":1737141277723,"author":{"id":3576143479038940,"idStr":"3576143479038940","authorId":3576143479038940,"authorIdStr":"3576143479038940","name":"Mike Yong","avatar":"https://community-static.tradeup.com/news/af67eb1674939c91d407718f5b29ebea","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"972123088c9646f7b6091ae0662215be-3","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Legendary Trader","description":"Total number of securities or futures transactions reached 300","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.23","exceedPercentage":"93.47%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":12,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;\nFaro Health and Recursion Partner To Advance AI-powered Clinical Trial Design\nPRESS RELEASE FROM FARO HEALTH\nSAN DIEGO — Faro Health Inc., the leading AI-powered platform for data-driven clinical protocol design, today announced it has partnered with Recursion (NASDAQ: RXRX) to accelerate and optimize clinical protocol design for Recursion’s portfolio of clinical-stage drug candidates.\n \nRead More At: https://www.biopharmadive.com/press-release/20250114-faro-health-and-recursion-partner-to-advance-ai-powered-clinical-trial-desi-1/\n\n </body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a><v-v data-views=\"1\"></v-v>&nbsp;\nFaro Health and Recursion Partner To Advance AI-powered Clinical Trial Design\nPRESS RELEASE FROM FARO HEALTH\nSAN DIEGO — Faro Health Inc., the leading AI-powered platform for data-driven clinical protocol design, today announced it has partnered with Recursion (NASDAQ: RXRX) to accelerate and optimize clinical protocol design for Recursion’s portfolio of clinical-stage drug candidates.\n \nRead More At: https://www.biopharmadive.com/press-release/20250114-faro-health-and-recursion-partner-to-advance-ai-powered-clinical-trial-desi-1/\n\n </body></html>","text":"$Recursion Pharmaceuticals, Inc.(RXRX)$ Faro Health and Recursion Partner To Advance AI-powered Clinical Trial Design PRESS RELEASE FROM FARO HEALTH SAN DIEGO — Faro Health Inc., the leading AI-powered platform for data-driven clinical protocol design, today announced it has partnered with Recursion (NASDAQ: RXRX) to accelerate and optimize clinical protocol design for Recursion’s portfolio of clinical-stage drug candidates. Read More At: https://www.biopharmadive.com/press-release/20250114-faro-health-and-recursion-partner-to-advance-ai-powered-clinical-trial-desi-1/","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://ttm.financial/post/393611147780552","repostId":0,"isVote":1,"tweetType":1,"viewCount":637,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["RXRX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":514,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/393611147780552"}